Most common all-grade TEAEs and grade 3/4 TEAEs
. | Patients (n = 28) . | |
---|---|---|
All-grade TEAEs (≥25%), n (%) . | Grade 3/4 TEAEs (>1 patient), n (%) . | |
Overall | 28 (100) | 20 (71.4) |
Diarrhea | 19 (67.9) | 4 (14.3) |
Fatigue | 15 (53.6) | 6 (21.4) |
Peripheral edema | 14 (50.0) | 4 (14.3) |
Anemia | 13 (46.4) | 4 (14.3) |
Constipation | 13 (46.4) | 0 |
Dizziness | 13 (46.4) | 0 |
Lymphopenia | 12 (42.9) | 5 (17.9) |
Nausea | 12 (42.9) | 0 |
Upper respiratory tract infection | 11 (39.3) | 1 (3.6) |
Hyperglycemia | 10 (35.7) | 0 |
Insomnia | 9 (32.1) | 1 (3.6) |
Dyspnea | 9 (32.1) | 0 |
Cough | 8 (28.6) | 0 |
Hypoalbuminemia | 7 (25.0) | 2 (7.1) |
Hyponatremia | 7 (25.0) | 2 (7.1) |
Hypokalemia | 7 (25.0) | 1 (3.6) |
Aspartate aminotransferase increased | 7 (25.0) | 0 |
Thrombocytopenia | 7 (25.0) | 1 (3.6) |
Fall | 6 (21.4) | 3 (10.7) |
Cellulitis | 4 (14.3) | 2 (7.1) |
Acute kidney injury | 3 (10.7) | 2 (7.1) |
Pneumonia | 3 (10.7) | 3 (10.7) |
Hypertension | 2 (7.1) | 1 (3.6) |
Syncope | 2 (7.1) | 2 (7.1) |
. | Patients (n = 28) . | |
---|---|---|
All-grade TEAEs (≥25%), n (%) . | Grade 3/4 TEAEs (>1 patient), n (%) . | |
Overall | 28 (100) | 20 (71.4) |
Diarrhea | 19 (67.9) | 4 (14.3) |
Fatigue | 15 (53.6) | 6 (21.4) |
Peripheral edema | 14 (50.0) | 4 (14.3) |
Anemia | 13 (46.4) | 4 (14.3) |
Constipation | 13 (46.4) | 0 |
Dizziness | 13 (46.4) | 0 |
Lymphopenia | 12 (42.9) | 5 (17.9) |
Nausea | 12 (42.9) | 0 |
Upper respiratory tract infection | 11 (39.3) | 1 (3.6) |
Hyperglycemia | 10 (35.7) | 0 |
Insomnia | 9 (32.1) | 1 (3.6) |
Dyspnea | 9 (32.1) | 0 |
Cough | 8 (28.6) | 0 |
Hypoalbuminemia | 7 (25.0) | 2 (7.1) |
Hyponatremia | 7 (25.0) | 2 (7.1) |
Hypokalemia | 7 (25.0) | 1 (3.6) |
Aspartate aminotransferase increased | 7 (25.0) | 0 |
Thrombocytopenia | 7 (25.0) | 1 (3.6) |
Fall | 6 (21.4) | 3 (10.7) |
Cellulitis | 4 (14.3) | 2 (7.1) |
Acute kidney injury | 3 (10.7) | 2 (7.1) |
Pneumonia | 3 (10.7) | 3 (10.7) |
Hypertension | 2 (7.1) | 1 (3.6) |
Syncope | 2 (7.1) | 2 (7.1) |